These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11257335)

  • 21. Current strategies and limitations of HIV vaccines.
    Kawalekar OU; Shedlock DJ; Weiner DB
    Curr Opin Investig Drugs; 2010 Feb; 11(2):192-202. PubMed ID: 20112169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Back to basics for HIV vaccine research.
    Senior K
    Lancet Infect Dis; 2008 Aug; 8(8):467. PubMed ID: 18705068
    [No Abstract]   [Full Text] [Related]  

  • 23. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization. Update: search for an AIDS vaccine.
    Bende S; Johnston MI
    AIDS Read; 2000 Sep; 10(9):526-32, 534-8. PubMed ID: 11019448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.
    Hone DM; DeVico AL; Fouts TR; Onyabe DY; Agwale SM; Wambebe CO; Blattner WA; Gallo RC; Lewis GK
    J Hum Virol; 2002; 5(1):17-23. PubMed ID: 12352264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards an HIV-1 vaccine: lessons from studies in macaque models.
    Hulskotte EG; Geretti AM; Osterhaus AD
    Vaccine; 1998; 16(9-10):904-15. PubMed ID: 9682336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trials of HIV vaccines.
    Graham BS
    Annu Rev Med; 2002; 53():207-21. PubMed ID: 11818471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.
    Belyakov IM; Ahlers JD
    Curr Top Microbiol Immunol; 2012; 354():157-79. PubMed ID: 21203884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV preventive vaccines. Progress to date.
    Esparza J; Osmanov S; Heyward WL
    Drugs; 1995 Nov; 50(5):792-804. PubMed ID: 8586027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
    Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
    J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?
    Sheppard N; Sattentau Q
    Expert Rev Mol Med; 2005 Feb; 7(2):1-21. PubMed ID: 15710051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress toward an HIV vaccine.
    Letvin NL
    Annu Rev Med; 2005; 56():213-23. PubMed ID: 15660510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A safe, effective and affordable HIV vaccine--an urgent global need.
    Joseph J; Etcheverry F; Alcami J; María GJ
    AIDS Rev; 2005; 7(3):131-8. PubMed ID: 16302460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered Expression of Broadly Neutralizing Antibodies Against Human Immunodeficiency Virus.
    Ahmad M; Ahmed OM; Schnepp B; Johnson PR
    Annu Rev Virol; 2017 Sep; 4(1):491-510. PubMed ID: 28645240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV vaccine development: perspective.
    Bolognesi DP
    Biotechnol Ther; 1991; 2(1-2):205-11. PubMed ID: 1845122
    [No Abstract]   [Full Text] [Related]  

  • 37. Prospects for vaccine protection against HIV-1 infection and AIDS.
    Letvin NL; Barouch DH; Montefiori DC
    Annu Rev Immunol; 2002; 20():73-99. PubMed ID: 11861598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV/AIDS vaccines: a need for new concepts?
    Girard MP; Bansal GP
    Int Rev Immunol; 2008; 27(6):447-71. PubMed ID: 19065351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventive HIV-1 vaccines: where are we going?
    Kent SJ
    Int J STD AIDS; 1998 Dec; 9(12):715-9. PubMed ID: 9874116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges in the development of an HIV-1 vaccine.
    Barouch DH
    Nature; 2008 Oct; 455(7213):613-9. PubMed ID: 18833271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.